Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

482
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
482
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.6K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.6K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

720
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
720
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

871
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
871
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

370
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
370

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degrader.

Nature communications·2026
Same author

Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Nonstandard Factor VIIa Binding Mode Reveals S1 Pocket Plasticity in Trypsin-Like Proteases.

ChemMedChem·2026
Same author

Upgrading Reliability in Molecular Property Prediction by Robust Quantification of Uncertainty from Machine Learning Models.

Journal of chemical information and modeling·2025
Same author

Building virtual patients using simulation-based inference.

Frontiers in systems biology·2025
Same author

Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference.

CPT: pharmacometrics & systems pharmacology·2025

Related Experiment Video

Updated: Apr 24, 2026

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

2.1K

Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time

Felix Jost1, Clemens Giegerich2, Christoph Grebner3

  • 1Translational Medicine Unit, Quantitative Pharmacology, Research Pharmacometrics, Sanofi R&D, Frankfurt, Germany.

CPT: Pharmacometrics & Systems Pharmacology
|April 23, 2026
PubMed
Summary
This summary is machine-generated.

Predicting pharmacokinetic (PK) profiles from molecular structures is now viable. Physics-informed neural networks (CMT-PINN) and decision trees (PURE-ML) show the highest accuracy for drug discovery, accelerating timelines.

Keywords:
PBPK (physiologically based pharmacokinetic)PINN (physics‐informed neural networks)compartmental modelingconcentration‐time profilesdrug discoverymachine learningmolecular structurepharmacokineticspredictive modeling

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.0K

Related Experiment Videos

Last Updated: Apr 24, 2026

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

2.1K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.0K

Area of Science:

  • Computational chemistry
  • Pharmacokinetics
  • Drug discovery

Background:

  • Accurate prediction of pharmacokinetic (PK) profiles from molecular structures is crucial for efficient drug discovery.
  • Existing methods often require extensive experimental data, delaying the process.

Purpose of the Study:

  • To systematically compare five distinct computational frameworks for predicting rat plasma concentration-time profiles directly from molecular structures.
  • To evaluate the performance of machine learning (ML) and physics-informed neural networks (PINNs) in PK prediction.

Main Methods:

  • Five methodologies were evaluated: NCA-ML, PBPK-ML, CMT-ML, CMT-PINN, and PURE-ML.
  • Models were trained and validated on a consistent dataset using a standardized evaluation framework.
  • Performance was assessed using R²-log, Spearman correlation, and percentage of predictions within twofold error.

Main Results:

  • The CMT-PINN approach demonstrated the highest predictive performance (R²-log: 0.854, Spearman: 0.933), closely followed by PURE-ML (R²-log: 0.789, Spearman: 0.896).
  • CMT-PINN and PURE-ML achieved 65.9% and 61.0% prediction accuracy within twofold error, respectively.
  • Models trained directly on concentration-time data outperformed those using derived PK parameters, especially with limited data.

Conclusions:

  • Predicting PK behavior from molecular structures before synthesis is feasible.
  • Computational approaches like CMT-PINN and PURE-ML enable informed compound selection early in drug discovery, reducing costs and timelines.
  • These methods have the potential to reduce reliance on animal studies and accelerate pharmaceutical development.